TrialInvestigational new drugs2013
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study.
Tim Eisen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled ittrialcites it